Medicare may soon cover Prolaris, Decipher tests for prostate cancer

Both Myriad Genetics and Genome DX Biosciences issued media releases today stating that Medicare contractors have issued draft coverage recommendations for tests used to assess the aggressiveness of prostate cancer based on genetic/genomic analyses of tissue from biopsy and post-surgical samples. … READ MORE …

Neurocrine (small cell) cancer of the prostate: an update

A new review article in the open access journal Oncology offers some key information about neuroendocrine (small-cell) carcinomas of the prostate (and why they offer essential lessons about the diagnosis and management of prostate cancer). … READ MORE …

Expert opinions on prevention, screening, and active surveillance

There are three new and useful resources now available related to the prevention of prostate cancer, screening for prostate cancer, and the role of active surveillance in the expectant management of prostate cancer. … READ MORE …

Testosterone supplements, rats, and risk for prostate cancer in healthy, aging men

The “New” Prostate Cancer InfoLink has long argued that the use of testosterone supplements by otherwise healthy men as they age (as a way to try to maintain the vigor and libido of their youth) comes with risks, and that one of those risks is the risk for a diagnosis of prostate cancer. … READ MORE …

Genomic/genetic tests for risk for clinically significant prostate cancer

The precise ability of the various genetic/genomic tests now available to accurately analyze the risk for clinically significant prostate cancer based on biopsy tissue samples is an important factor that all of the different developers and manufacturers of these tests continue to study in greater detail. … READ MORE …

Active surveillance among African-American males — some confusion

The appropriateness and utility of active surveillance as a management strategy for African-American men diagnosed with low-risk forms of prostate cancer appears to be becoming an issue of some mild controversy. … READ MORE …

Genetic profiling and the future management of prostate cancer

A recent review article from Future Oncology, just posted in full on the Medscape Oncology web site, addresses the evolving topic of how we can translate our knowledge about genetic risk factors for prostate cancer into practical processes that can be used routinely by clinicians. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,151 other followers